Anaplastic Thyroid Cancer
Conditions
Keywords
anaplastic thyroid cancer
Brief summary
Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical study, both positive and negative. The goal is to identify the obstacles and challenges that prevent participation in anaplastic thyroid cancer clinical research, as well as the reasons for withdrawal or discontinuation. Insights gained from this study will ultimately benefit those with anaplastic thyroid cancer who may be invited to participate in clinical research in the years to come.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosed with anaplastic thyroid cancer * Willing to comply with all study related procedures and assessments * Capable of giving signed informed consent, which includes compliance with requirements and restrictions listed in the informed consent form (ICF) and in the protocol
Exclusion criteria
* No documented diagnosis of anaplastic thyroid cancer * Any serious and/or unstable pre-existing medical disorders * Pregnant or lactating woman
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of anaplastic thyroid cancer patients who remain in a clinical study to completion | 12 months |
| Number of anaplastic thyroid cancer patients who decide to enroll in a clinical study | 3 months |
Contacts
Primary ContactMichael B Gill
Outcome results
None listed